Lord Sarfraz visited Singapore in his capacity as the Prime Minister's Trade Envoy. During his visit, he witnessed, alongside Singapore's Minister for Health, the launch of GSK's new High Potency Facility which produces a key ingredient, a cytotoxic component, in antibody drug conjugates (ADCs) to treat cancer.
He also met with businesses to seek their input on the UK-Singapore Green Economy Framework Agreement, attended the Bloomberg New Economy Forum, visiting a UK tech firm operating critical drone services, and met with officials at Singapore's Ministry of Trade & Industry.
